Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases

Background: Cardiometabolic morbidity and medications, specifically Angiotensin Converting Enzyme inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs), have been linked with adverse outcomes from coronavirus disease 2019 (COVID-19). This study aims to investigate, factors associated with COVID...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Cardiovasc Med
Hauptverfasser: Raisi-Estabragh, Zahra, McCracken, Celeste, Ardissino, Maddalena, Bethell, Mae S., Cooper, Jackie, Cooper, Cyrus, Harvey, Nicholas C., Petersen, Steffen E.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2020
Schlagworte:
Cardiovascular Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7381180/
https://ncbi.nlm.nih.gov/pubmed/32766285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2020.00138
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge